Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-16 Sale | 2024-04-17 6:42 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $9.28 | $928,005 | 10,898,669 (Indirect Direct) | View |
| 2024-04-16 Sale | 2024-04-17 6:40 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $9.28 | $928,005 | 10,898,669 (Indirect Direct) | View |
| 2024-04-09 Sale | 2024-04-10 5:39 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $9.2773 | $927,735 | 10,999,622 (Indirect Direct) | View |
| 2024-04-09 Sale | 2024-04-10 5:36 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $9.2773 | $927,735 | 10,999,622 (Indirect Direct) | View |
| 2024-03-25 Purchase | 2024-03-27 7:37 pm | ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,401,299 | $9.4836 | $13,289,410 | 10,860,977 (Indirect) | View |
| 2024-03-22 Sale | 2024-03-26 6:48 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 97,610 | $9.1212 | $890,322 | 11,048,669 (Indirect Direct) | View |
| 2024-03-22 Sale | 2024-03-26 6:47 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 97,610 | $9.1212 | $890,322 | 11,048,669 (Indirect Direct) | View |
| 2024-03-19 Sale | 2024-03-21 9:51 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 2,390 | $9.026 | $21,572 | 11,097,627 (Indirect Direct) | View |
| 2024-03-19 Sale | 2024-03-21 9:50 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 2,390 | $9.026 | $21,572 | 11,097,627 (Indirect Direct) | View |
| 2024-03-13 Sale | 2024-03-15 7:55 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $9.1368 | $913,681 | 11,149,622 (Indirect Direct) | View |
| 2024-03-13 Sale | 2024-03-15 7:52 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $9.1368 | $913,681 | 11,149,622 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-01 8:21 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 3,782 | $9.0165 | $34,101 | 9,151,123 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-01 8:17 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 3,782 | $9.0165 | $34,101 | 9,151,123 (Indirect Direct) | View |
| 2024-02-26 Sale | 2024-02-28 9:08 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 99,478 | $9.0208 | $897,368 | 9,152,123 (Indirect Direct) | View |
| 2024-02-26 Sale | 2024-02-28 9:04 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 99,478 | $9.0208 | $897,368 | 9,152,123 (Indirect Direct) | View |
| 2023-09-28 Purchase | 2023-10-02 4:23 pm | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 86,258 | $3.7093 | $319,954 | 89,227 (Direct) | View |
| 2023-09-21 Purchase | 2023-09-25 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director | 2,700,000 | $3.0309 | $8,183,526 | 9,459,678 (Indirect) | View |
| 2023-09-01 Sale | 2023-09-05 8:04 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $7.7052 | $770,520 | 265,581 (Direct) | View |
| 2023-08-29 Purchase | 2023-08-31 5:26 pm | ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director | 3,750,000 | $6.2 | $23,250,000 | 6,759,678 (Indirect) | View |
| 2023-08-29 Purchase | 2023-08-31 5:26 pm | ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director | 500,000 | $6.2 | $3,100,000 | 9,240,887 (Indirect) | View |
| 2023-08-29 Purchase | 2023-08-31 5:18 pm | ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director | 500,000 | $6.2 | $3,100,000 | 9,240,887 (Indirect) | View |
| 2023-08-03 Sale | 2023-08-07 5:05 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 45,004 | $7.0325 | $316,489 | 235,237 (Direct) | View |
| 2023-08-01 Sale | 2023-08-03 6:03 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 54,996 | $7.1249 | $391,841 | 342,629 (Direct) | View |
| 2023-07-07 Sale | 2023-07-07 8:16 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 8,858 | $6.364 | $56,372 | 313,343 (Direct) | View |
| 2023-07-03 Sale | 2023-07-06 8:55 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 91,142 | $6.4784 | $590,453 | 644,043 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-23 Exercise | 2024-04-24 6:18 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 48,260 | $1.44 | 12,900,073 (Direct) | View |
| 2024-04-23 Exercise | 2024-04-24 6:18 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 82,733 | $0.84 | 12,900,073 (Direct) | View |
| 2024-04-23 Exercise | 2024-04-24 6:18 pm | N/A 2029-12-16 | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 130,993 | $0 | 12,900,073 (Direct) | View |
| 2024-04-23 Exercise | 2024-04-24 6:17 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 48,260 | $1.44 | 12,900,073 (Indirect) | View |
| 2024-04-23 Exercise | 2024-04-24 6:17 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 82,733 | $0.84 | 12,900,073 (Indirect) | View |
| 2024-04-23 Exercise | 2024-04-24 6:17 pm | N/A 2029-12-16 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 130,993 | $0 | 12,900,073 (Indirect) | View |
| 2024-04-19 Exercise | 2024-04-22 7:23 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 69,444 | $1.44 | 13,018,876 (Indirect) | View |
| 2024-04-19 Exercise | 2024-04-22 7:23 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 119,047 | $0.84 | 13,018,876 (Indirect) | View |
| 2024-04-19 Exercise | 2024-04-22 7:23 pm | N/A 2029-12-16 | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 188,491 | $0 | 13,018,876 (Indirect) | View |
| 2024-04-19 Exercise | 2024-04-22 7:22 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 69,444 | $1.44 | 13,018,876 (Direct) | View |
| 2024-04-19 Exercise | 2024-04-22 7:22 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 119,047 | $0.84 | 13,018,876 (Direct) | View |
| 2024-04-19 Exercise | 2024-04-22 7:22 pm | N/A 2029-12-16 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 188,491 | $0 | 13,018,876 (Direct) | View |
| 2023-05-17 Gift | 2024-01-04 4:53 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E President and CEO 10% Owner | 1,050,000 | $0 | 10,952,522 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:53 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E President and CEO 10% Owner | 1,180,000 | $0 | 10,952,522 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:47 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-05-17 Gift | 2024-01-04 4:45 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina Chief Medical Officer 10% Owner | 1,050,000 | $0 | 10,102,554 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:45 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina Chief Medical Officer 10% Owner | 1,180,000 | $0 | 10,102,554 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:42 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:41 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:39 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:38 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-05 8:04 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $1.27 | 265,581 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-05 8:04 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $0 | 265,581 (Direct) | View |
| 2023-08-03 Exercise | 2023-08-07 5:05 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 45,004 | $1.27 | 235,237 (Direct) | View |
| 2023-08-03 Exercise | 2023-08-07 5:05 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 44,914 | $0 | 235,237 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-03 6:03 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 54,996 | $1.27 | 342,629 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-03 6:03 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 54,996 | $0 | 342,629 (Direct) | View |
| 2023-07-07 Exercise | 2023-07-07 8:16 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 8,858 | $1.27 | 313,343 (Direct) | View |
| 2023-07-07 Exercise | 2023-07-07 8:16 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 8,858 | $0 | 313,343 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 8:55 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 91,142 | $1.27 | 644,043 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 8:55 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 91,142 | $0 | 644,043 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-28 9:03 pm | N/A 2033-06-26 | ARS Pharmaceuticals Inc. | SPRY | Dadoo Rajeev Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-28 9:00 pm | N/A 2033-06-26 | ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director | 40,000 | $0 | 40,000 (Indirect) | View |
| 2023-06-27 Option Award | 2023-06-28 9:00 pm | N/A 2033-06-26 | ARS Pharmaceuticals Inc. | SPRY | Kelly Michael Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-28 9:00 pm | N/A 2033-06-26 | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |